Starling Oncology, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net
Starling Oncology, Inc. (DFPH) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net of $0 for the 9-month period ending 2021-09-30, per its 10-Q/A filed 2021-12-14.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet · last filed 2021-12-14
- Starling Oncology, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers, net for the quarter ending 2021-09-30 was $0.00.
- Starling Oncology, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers, net for the quarter ending 2021-06-30 was $0.00.
- Starling Oncology, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers, net for the quarter ending 2021-03-31 was $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net 9 month |
|---|---|---|---|
| 2021-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2021-12-14 | $0.00 derived: sum of 2 quarters · filed 2021-12-14 | $0.00 10-Q/A · filed 2021-12-14 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-28 |